Regulatory T cells in cancer immunotherapy

Tanaka, Atsushi, Sakaguchi, Shimon·2017·Cell Research

DOI 10.1038/cr.2016.151

Cited by (1,001)

Items 501–600 of 1,001

Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Xubin Li, Elisabeth Kong, Gonghong Yan, Zeynep Dereli, Behnaz Bozorgui, Parisa Imanirad, Jacob H. Elnaggar, Augustin Luna, David G. Menter, Patrick Glen Pilie et al. · 2022 · Cancer Discovery
The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review
Désage, Anne-Laure, Karpathiou, Georgia, Peoc’h, Michel, Froudarakis, Marios E. · 2021 · Cancers
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect
Chunqi Zhu, Yingying Shi, Qingpo Li, Lihua Luo, Xiang Li, Zhenyu Luo, Yichao Lu, Junlei Zhang, Mengshi Jiang, Bing Qin et al. · 2021 · Journal of Controlled Release
Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review)
Анна Казакова, Tatiana Sudarskikh, Oleg I. Kovalev, Julia G. Kzhyshkowska, Irina Larionova · 2023 · International Journal of Oncology
Nanoparticle-based immunotherapeutics: From the properties of nanocores to the differential effects of administration routes
André Perez‐Potti, Manuel Rodríguez-Pérez, Ester Polo, Beatriz Pelaz, Pablo del Pino · 2023 · Advanced Drug Delivery Reviews
Actin-related protein 2/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT/PI3K/mTOR signaling pathway
Miao Ke, Huimin Zhu, Yu Wei Lin, Ying Zhang, Tao Tang, Yuhao Xie, Zhe‐Sheng Chen, Xiaoyu Wang, Yuan Li Shen · 2024 · Journal of Translational Internal Medicine
Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer
Julia H. Carter, James A. Deddens, Gretchen Mueller, Thomas G. Lewis, Mariah K. Dooley, Michelle C. Robillard, Molly Frydl, Lydia R. Duvall, Jackson O. Pemberton, Larry E. Douglass · 2018 · British Journal of Cancer
The role of miR-183 cluster in immunity
Kenji Ichiyama, Chen Dong · 2018 · Cancer Letters
Cutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms
Isao Otsuka · 2019 · International Journal of Molecular Sciences
Role of cancer immunology in chronic myelogenous leukemia
Hiroshi Ureshino, Takero Shindo, Shinya H Kimura · 2019 · Leukemia Research
The Impact of Estrogen in the Tumor Microenvironment
Ashwin Somasundaram, Natalie J. Rothenberger, Laura P. Stabile · 2020 · Advances in experimental medicine and biology
Metabolic profiles of regulatory T cells in the tumour microenvironment
Disha Rao, Fabienne Verburg, Kathrin Renner, Daniel S. Peeper, Ruben Lacroix, Christian U. Blank · 2021 · Cancer Immunology Immunotherapy
Two sides of the same coin: Protective versus pathogenic CD4 + resident memory T cells
Anna E. Oja, René A. W. van Lier, Pleun Hombrink · 2022 · Science Immunology
Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer
İsmail Yaman, Didem Ağaç Çobanoğlu, Tongxin Xie, Yi Ye, Moran Amit · 2022 · Pharmacology & Therapeutics
The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
Che-Wei Wang, Pulak Kumar Biswas, Atikul Islam, Mu‐Kuan Chen, Pin Ju Chueh · 2024 · Cells
Loss of chromosome Y in regulatory T cells
Jonas Mattisson, Jonatan Halvardson, Hanna Davies, Bożena Bruhn‐Olszewska, Paweł Olszewski, Marcus Danielsson, Josefin Bjurling, Amanda Lindberg, Ammar Zaghlool, Edyta Rychlicka-Buniowska et al. · 2024 · BMC Genomics
Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer
Qian Chen, Meiying Shen, Min Yan, Xiaojian Han, Song Mu, Ya Li, Li Luo, Yingming Wang, Shenglong Li, Tingting Li et al. · 2024 · Journal of Translational Medicine
Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
Shuxi Yao, Xinyue Liu, Yanqi Feng, Yiming Li, Xiangtian Xiao, Yuelin Han, Shu Xia · 2024 · International Journal of Molecular Sciences
The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infections
Ahmad Karkhah, Mostafa Javanian, Soheil Ebrahimpour · 2018 · Infection Genetics and Evolution
Polymeric nucleic acid delivery for immunoengineering
Stephany Yi Tzeng, Jordan J. Green · 2018 · Current Opinion in Biomedical Engineering
Control of Regulatory T Cells by Co-signal Molecules
James B. Wing, Christopher Tay, Shimon Sakaguchi · 2019 · Advances in experimental medicine and biology
Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
Jochen Greiner, Marlies Götz, Donald Werner Bunjes, Susanne Hofmann, Verena Wais · 2019 · Journal of Clinical Medicine
Gaussian graphical model‐based heterogeneity analysis via penalized fusion
Mingyang Ren, Sanguo Zhang, Qingzhao Zhang, Shuangge Ma · 2021 · Biometrics
Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues
Tamara G. Dacoba, Shubaash Anthiya, Germán Berrecoso, Iago Fernández‐Mariño, Carmen Fernández‐Varela, José Crecente‐Campo, Desirée Teijeiro‐Osorio, Fernando Torres, Marı́a José Alonso · 2021 · Advanced Functional Materials
Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer
Xuan Lin, Hedan Chen, Ying Xie, Xue Mei Zhou, Yun Wang, Jing Zhou, Shiqi Long, Zuquan Hu, Shichao Zhang, Wei Qiu et al. · 2021 · Translational Oncology
Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi, Masahiro Ogasawara · 2021 · Human Vaccines & Immunotherapeutics
Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma
Dalam Ly, Quan Li, Roya Navab, Cédric Zeltz, Linan Fang, Michael Cabanero, Chang‐Qi Zhu, Ming‐Sound Tsao, Li Zhang · 2021 · Cancers
Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy
Qiankun Ni, Fengfei Xu, Yufei Wang, Yujie Li, Guangchao Qing, Yuxuan Zhang, Jie Zhong, Jinghong Li, Xing‐Jie Liang · 2022 · Journal of Controlled Release
Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity
Zhongyi Jiang, Haitao Zhu, Pusen Wang, Weitao Que, Lin Zhong, Xiao‐Kang Li, Futian Du · 2022 · MedComm
Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
Jiaqi Liang, Guoshu Bi, Guangyao Shan, Xing Jin, Yunyi Bian, Qun Wang · 2022 · Journal of Immunology Research
Recent Developments in Nanoparticle‐Based Photo‐Immunotherapy for Cancer Treatment
Zhongyuan Guo, Audrey T. Zhu, Ronnie H. Fang, Liangfang Zhang · 2023 · Small Methods
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment
Duocai Li, Weidong Xu, Yifan Emily Chang, Yu‐Tian Xiao, Yundong He, Shancheng Ren · 2023 · Acta Biochimica et Biophysica Sinica
OMIP‐095 : 40‐Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues
Aris J. Kare, Lisa A. Nichols, Ricardo Zermeno, Marina Nura Raie, Spencer K. Tumbale, Katherine W. Ferrara · 2023 · Cytometry Part A
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
Yukai Shan, Tian-Ao Xie, Yuchao Sun, Zi-Yi Lu, Win Topatana, Sarun Juengpanich, Tian-Bin Chen, Yina Han, Jiasheng Cao, Jiahao Hu et al. · 2024 · Biomarker Research
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy
Mostafa Yazdimamaghani, Oleg Kolupaev, Chaemin Lim, Duhyeong Hwang, Sonia J. Laurie, Charles M. Perou, Alexander V. Kabanov, Jonathan Stuart Serody · 2024 · Biomaterials
Immunoregulation and male reproductive function: Impacts and mechanistic insights into inflammation
Ying-Jie Ma, Xin-Ru Yu, Yi-Fan Liu, Bihan Song, Zhen-Gao Sun, Shengtian Zhao · 2024 · Andrology
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
Isabelle Magalhaes, Claudia Carvalho‐Queiroz, Ciputra Adijaya Hartana, Andreas Marius Kaiser, Ana Lukic, Michael Mints, Ola Nilsson, Hans Grönlund, Jonas Mattsson, Sofia Berglund · 2019 · Expert Opinion on Biological Therapy
Applications of Single-Cell Omics to Dissect Tumor Microenvironment
Tingting Guo, Weimin Li, Xuyu Cai · 2020 · Frontiers in Genetics
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study
Christoffer Gebhardt, Sonja C. S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael R. Reinhard, Tim Holland‐Letz, Viktor Umansky, Jochen Sven Utikal · 2020 · Cellular Immunology
Monoclonal Antibody Therapies for High Risk Neuroblastoma
Wayne Lee Furman · 2021 · Biologics
Cellular based immunotherapy for primary liver cancer
Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou et al. · 2021 · Journal of Experimental & Clinical Cancer Research
Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application
Masatsugu Miyashita, Teruki Shimizu, Eishi Ashihara, Osamu Ukimura · 2021 · International Journal of Molecular Sciences
Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity
Joseph W. Dean, Liang Zhou · 2022 · Trends in Immunology
The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer
Lingling Zu, Jinling He, Ning Zhou, Jingtong Zeng, Yifang Zhu, Quanying Tang, Xin Jin, Lei Zhang, Song Xu · 2022 · Journal of Clinical Medicine
IL-10-Producing B Cells Suppress Effector T Cells Activation and Promote Regulatory T Cells in Crystalline Silica-Induced Inflammatory Response In Vitro
Yi‐Ping Lu, Fangwei Liu, Chao Li, Ying Chen, Dong Weng, Jie Chen · 2017 · Mediators of Inflammation
Recruitment of Regulatory T Cells with rCCL17 Promotes M2 Microglia/Macrophage Polarization Through TGFβ/TGFβR/Smad2/3 Pathway in a Mouse Model of Intracerebral Hemorrhage
Shuixiang Deng, Peng Jin, Shengpeng Liu, Lei Huang, Prativa Sherchan, Yuhui Cui, John H. Zhang, Ye Gong, Jiping Tang · 2021 · Experimental Neurology
Blocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy
Fusheng Si, Xia Liu, Yan Tao, Yuanqin Zhang, Feiya Ma, Eddy C. Hsueh, Sidharth V. Puram, Guangyong Peng · 2024 · Journal for ImmunoTherapy of Cancer
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Andrea Ziblat, Brendan L. Horton, Emily F. Higgs, Ken Hatogai, Anna Martinez, Jason W. Shapiro, Danny EC Kim, Yuanyuan Zha, Randy F. Sweis, Thomas Frank Gajewski · 2024 · Cell Reports
Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer
Yan Wang, Yanhong Chen, Ding‐Kun Ji, Yuelin Huang, Weixi Huang, Xue Dong, Defan Yao, Dengbin Wang · 2024 · Journal of Nanobiotechnology
T cells in cancer: mechanistic insights and therapeutic advances
Jingjing Pu, Ting Liu, Yi Zhou, Mengping Chen, Xuehang Fu, Yike Wan, Junying Wang, Binzhen Chen, Amit Sharma, Veronika Lukacs‐Kornek et al. · 2025 · Biomarker Research
T Cell Metabolism in Cancer Immunotherapy
Halil‐Ibrahim Aksoylar, Natalia M. Tijaro-Ovalle, Vassiliki A. Boussiotis, Nikolaos Patsoukis · 2020 · Immunometabolism
Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy
Wenjun Zhang · 2021 · Purinergic Signalling
Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics
Yang Du, Qiannan Fang, Song Guo Zheng · 2021 · Advances in experimental medicine and biology
Prolonged exposure to the herbicide atrazine suppresses immune cell functions by inducing spleen cell apoptosis in rats
Jingyan Ge, Jian Liu, Taiwei Wang, Di Huang, Junwei Li, Shuang Zhang, Mengqi Wang, Wei Yong Liu, Lijing Zhao · 2021 · Ecotoxicology and Environmental Safety
Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance
Mingyi Shen, Yanhua Du, Youqiong Ye · 2021 · Medical Review
Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations
Wenjing Zhang, Yunfeng Tang, Yuxian Guo, Yujia Kong, Fuyan Shi, Chao Sheng, Suzhen Wang, Qinghua Wang · 2022 · npj Precision Oncology
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models
Haohai Zhang, Lili Feng, Paola de Andrade Mello, Changchuin Mao, Richard I. Near, Eva Csizmadia, Leo Li‐Ying Chan, Keiichi Enjyoji, Wenda Gao, Haitao Zhao et al. · 2022 · Journal of Clinical Investigation
Vaccination of Urological Cancer Patients With WT1 Peptide‐Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses
Masahiro Ogasawara, Mamiko Miyashita, Shuichi Ota · 2018 · Therapeutic Apheresis and Dialysis
The pro- and anti-tumor role of ILC2s
Sara Trabanelli, Mathieu F. Chevalier, Laurent Derré, Camilla Jandus · 2019 · Seminars in Immunology
Anti-Tumor Effect of Parasitic Protozoans
Haojie Ding, Songrui Wu, Zi Jin, Bin Zheng, Yuan Hu, Ke He, Shaohong Lu, Xunhui Zhuo · 2022 · Bioengineering
Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity
Zhaoting Li, Yueyang Deng, Honghao Sun, Caixia Tan, Heming Li, Fanyi Mo, Yixin Wang, Jing Li, Zhanwei Zhou, Minjie Sun · 2023 · Journal of Controlled Release
Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment
Wanling Zhu, Xiaowei Liu, Lei Yang, Qiang He, Dingming Huang, Xuelian Tan · 2023 · European Journal of Pharmacology
Tryptanthrin targets GSTP1 to induce senescence and increases the susceptibility to apoptosis by senolytics in liver cancer cells
Yuxuan Zhang, Biying Xiao, Shuying Yuan, Lele Ding, Yongfu Pan, Yanyu Jiang, Shenghao Sun, Xisong Ke, Lili Cai, Lijun Jia · 2024 · Redox Biology
N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma
Weiguo Xu, Bin Zhou, Ping Wang, Yuyan Ma, Jiang Yu, Dongping Mo, Jun Wu, Jingjing Ma, Xiao Wang, Yinxing Miao et al. · 2024 · Drug Resistance Updates
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It
Magdalena K. Zielińska, Magdalena A. Ciążyńska, Dorota Sulejczak, Piotr Lukasz Rutkowski, Anna Malgorzata Czarnecka · 2025 · Biomolecules
Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma
Haojie Dai, Xi Zhang, Lu Yin, Hongqi Chen, Kui Liu, Li Jian, Heng Li, Lian Sheng, Huan Wu, Jiawei Wang et al. · 2026 · Cancer Cell International
Matrix metalloproteinase 12 expression is associated with tumor FOXP3+ regulatory T cell infiltration and poor prognosis in hepatocellular carcinoma
Minke He, Yong Le, Yong‐Fa Zhang, Hanyue Ouyang, Pei-en Jian, Zi‐Shan Yu, Lijuan Wang, Ming Shi · 2018 · Oncology Letters
CD70 expression in tumor-associated fibroblasts predicts worse survival in colorectal cancer patients
Satoshi Inoue, Hideaki Ito, Takumi Tsunoda, Hideki Murakami, Masahide Ebi, Naotaka Ogasawara, Kunio Kasugai, Kenji Kasai, Hiroshi Ikeda, Shingo Inaguma · 2019 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma
Huijuan Yang, Shuang Ye, Shyamal Goswami, Teng Li, Jingwen Wu, Chunmei Cao, Jiaqiang Ma, Bin Lu, Xuan Pei, Yanan Chen et al. · 2019 · International Journal of Cancer
Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma
Ran Xia, Jinyuan Xiao, Yi Zhang, Huajing Teng, Fang Cheng, Huiqian Chen, Kaifan Zhang, Zhongsheng Sun · 2020 · Therapeutic Advances in Medical Oncology
A tumor-specific mechanism of T reg enrichment mediated by the integrin αvβ8
Robert Seed, Kenji Kobayashi, Saburo Ito, Naoki Takasaka, Anthony Cormier, Jillian M. Jespersen, Jean Publicover, Suprita Trilok, Alexis J. Combes, Nayvin W. Chew et al. · 2021 · Science Immunology
Role of CD4+CD25+FOXP3+TRegcells on tumor immunity
Agustinus Darmadi Hariyanto, Tiara Bunga Mayang Permata, Soehartati Argadikoesoema Gondhowiardjo · 2021 · Immunological Medicine
lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration
Yunkun Yan, Jianjun Liu, Zhijian Xu, Mushi Ye, Jianchang Li · 2021 · Disease Markers
Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity
Yonglin Chen, Manxue Jia, Sharon Wang, Sherry Xu, Nanhai He · 2022 · Frontiers in Immunology
Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity
Christophe Pedros, Ann J. Canonigo-Balancio, Kok‐Fai Kong, Amnon Altman · 2017 · JCI Insight
Systemic delivery of glycosylated-PEG-masked oncolytic virus enhances targeting of antitumor immuno-virotherapy and modulates T and NK cell infiltration
Yuzhi Liang, Bing Wang, Qingjing Chen, Xingyue Fu, Chenwei Jiang, Zhiwen Lin, Qiuyu Zhuang, Yongyi Zeng, Xiaolong Liu, Da Zhang · 2023 · Theranostics
Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy
Miaomiao Chen, Si-Liang Wang · 2024 · International Immunopharmacology
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
Ana Dillen, Indy Bui, Megan Jung, Stephanie Agioti, Apostolos Zaravinos, Benjamin Bonavida · 2024 · Cancers
Quercetin exerts anti-tumor immune mechanism by regulating IL-6/JAK2/STAT3 signaling pathway to deplete Treg cells.
Yupei Liao, Xiaoqing Xie, Chunyong Zhang, Haijing Zhong, L. Shan, Pei Yu, Li-Peng Xu · 2024 · Toxicon
Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy
Yanting Liu, Fang Liu, Yan Zeng, Liangbin Lin, Hui Yu, Sunfu Zhang, Wenyong Yang · 2024 · Frontiers in Cell and Developmental Biology
Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma
Miao‐Fen Chen, Ming‐Shao Tsai, Wen‐Cheng Chen, Ping‐Tsung Chen · 2018 · Journal of Clinical Medicine
Dormant pathogenic CD4+ T cells are prevalent in the peripheral repertoire of healthy mice
Anna Cebula, Michal Kuczma, Edyta A. Szurek, Maciej Pietrzak, Natasha M. Savage, Wessam R. Elhefnawy, Grzegorz A. Rempała, Piotr Jan Kraj, Leszek Ignatowicz · 2019 · Nature Communications
Targeting ST2 expressing activated regulatory T cells in Kras-mutant lung cancer
Byung Seok Kim, Jelita Clinton, Qing Wang, Seon Hee Chang · 2019 · OncoImmunology
oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity
Wen Zhang, Xiao Hu, Jing Liang, Yujie Zhu, Beibei Zeng, Lin Feng, Changyun Zhao, Shangmei Liu, Binlei Liu, Kaitai Zhang · 2020 · Molecular Therapy — Oncolytics
The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments
Sophie Outh-Gauer, Aurélien Morini, Éric Tartour, Charles Lépine, Alain C. Jung, Cécile Badoual · 2020 · Head and Neck Pathology
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma
Kavitha Premkumar, Bhavani S. Shankar · 2020 · Cancer Immunology Immunotherapy
Chemokine-like factor 1: A promising therapeutic target in human diseases
Xiaopeng Cai, Jingwen Deng, Qianqian Ming, Huiqiang Cai, Zhi Chen · 2020 · Experimental Biology and Medicine
microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer
Weidan Fang, Chao Shi, Yiting Wang, Jianping Song, Ling Zhang · 2021 · Bioengineered · Retracted
Targeting Tumour-Associated Fibroblasts in Cancers
Kairav Shah, Sanchari Basu Mallik, Praveer K. Gupta, Abishek Iyer · 2022 · Frontiers in Oncology
Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines
Rui Freitas, Andreia Peixoto, Eduardo Ferreira, Andréia Miranda, Lúcio Lara Santos, José Alexandre Ferreira · 2023 · Biotechnology Advances
CD8+CD28−CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?
Daniela Fenoglio, Chiara Dentone, Alessio Signori, Antonio Di Biagio, Alessia Parodi, Francesca Kalli, Giorgia Nasi, Monica Curto, Giovanni Cenderello, Pasqualina De Leo et al. · 2017 · Journal of Allergy and Clinical Immunology
Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion
Sang Jun Han, Prashi Jain, Yosef Gilad, Yan Xia, Nuri Sung, Mi Jin Park, Adam M. Dean, Rainer B. Lanz, Jianming Xu, Clifford C. Dacso et al. · 2023 · Proceedings of the National Academy of Sciences
Combined mild magnetic hyperthermia and calcium ion regulation for enhanced immunotherapy of orthotopic liver cancer
Lizhu Chen, Weiwei Ren, Qunqun Bao, Ping Hu, Wenming Fang, Tong Wu, Jianlin Shi · 2024 · Nano Today
The Roles of Gut Microbiota Metabolites in the Occurrence and Development of Colorectal Cancer: Multiple Insights for Potential Clinical Applications
Wenyue Cheng, Fan Li, Rongcun Yang · 2024 · Gastro Hep Advances
The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma
Hao Wang, Lin Yao, Jinming Chen, Yanyan Li, Zuopeng Su, Yongsheng Liu, Wen Li, Yun Xiong, Heyang Gao, Xiao Zhang et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Mitoxantrone‐Encapsulated ZIF‐8 Enhances Chemo‐Immunotherapy via Amplified Immunogenic Cell Death
Junhong Li, Wenxing Lv, Ziwei Han, Yike Li, Jinqi Deng, Yanjuan Huang, Shuo Wan, Jiashu Sun, Bo Dai · 2025 · Advanced Science
Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations
Louis Szeponik, Filip Ahlmanner, Patrik Sundström, William Carl Ivar Rodin, Bengt G. Gustavsson, Elinor Bexe Lindskog, Yvonne Wettergren, Marianne Quiding‐Järbrink · 2021 · BMC Immunology
Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
Huey-Jen L. Lin, Yingguang Liu, Denene Lofland, Jiayuh Lin · 2022 · Cancers
Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy
Ran Gao, Guo‐Ping Shi, Jing Wang · 2022 · Frontiers in Immunology
Immunogenic Nanovesicle‐Tandem‐Augmented Chemoimmunotherapy via Efficient Cancer‐Homing Delivery and Optimized Ordinal‐Interval Regime
Mengchi Sun, Wen Shi, Yuxia Wu, Zhonggui He, Jin Sun, Shuang Cai, Qiuhua Luo · 2022 · Advanced Science